|
⚲
|
| Keyboard |
| Douglas Ingram | |
|---|---|
| Firm | |
| Address | c/o Relay Therapeutics, Inc 399 Binney Street, 2nd Floor Cambridge, MA 02139 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Relay Therapeutics Inc | 021-502011 | Director | 30.0 M of 30.0 M |
||
| Sarepta Therapeutics Inc | 021-361658 | Executive Officer | 400.0 M of 400.0 M |
||
| Sarepta Therapeutics Inc | 021-354185 | Executive Officer | 30.5 M of 30.5 M |
||
| Nemus Bioscience Inc | 021-298700 | Director | 2.0 M of 2.0 M |
||
| Nemus Bioscience Inc | 021-278343 | Director | 1.2 M of 1.5 M |
||
| Nemus Bioscience Inc | 021-273786 | Executive Officer | 0.5 M of 0.5 M |
||
| Chase Pharmaceuticals Corp | 021-257591 | Executive Officer | of 0.1 M |
||
| Chase Pharmaceuticals Corp | 021-257589 | Executive Officer | of 0.6 M |
||
| Nemus Bioscience Inc | 021-246531 | Executive Officer | 5.0 M of 5.0 M |
||
| Chase Pharmaceuticals Corp | 021-246193 | Director | 3.5 M of 3.5 M |
||